Skip to main content
Autobound logo

Regeneron news in 2026: 23 dated events

The latest Regeneron event on this page is dated Sep 24, 2026. globenewswire.com reported: Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026.

Public (REGN)Biotechnology Research10,000+ employeesregeneron.comLinkedIn

Dated events
26
Last 90 days
9
Latest
Sep 24, 2026

News · latest 10

Latest Regeneron news

  1. Earnings
    Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026Regeneron Pharmaceuticals will report its third quarter 2026 financial and operating results on October 30, 2026.
    globenewswire.com
  2. In development
    Paroxysmal Nocturnal Hemoglobinuria Market Forecast Upto 2036: 5 Emerging Therapies Poised to Accelerate Market GrowthRegeneron Pharmaceuticals is developing Pozelimab + Cemdisiran, a potential therapy for paroxysmal nocturnal hemoglobinuria (PNH).
    prnewswire.com
  3. Launch
    Regeneron Pharmaceuticals (REGN) Wins FDA Approval For Pasatru In Adult FOPRegeneron Pharmaceuticals received FDA approval for its drug Pasatru (garetosmab grts) to treat adults with fibrodysplasia ossificans progressiva (FOP).
    finance.yahoo.com
  4. Integration
    Veeva Vault CRM Selected by RegeneronWith Veeva Systems
    prnewswire.com
  5. In development
    Regeneron (REGN) Wins FDA Approval For Pasatru In Ultra-Rare Bone-Forming DiseaseRegeneron Pharmaceuticals plans to begin a paediatric trial for its newly approved FOP drug, Pasatru, later this year.
    londoninsider.co.uk
  6. Investment
    Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business UpdatesRegeneron made a $125 million equity investment and upfront payment into Parabilis Medicines as part of a strategic research collaboration.
    manilatimes.net
  7. In development
    Regeneron Pharmaceuticals Q2 Earnings Call HighlightsWith U.S. Food and Drug Administration · 3 stories
    tradingview.com
  8. Revenue
    Regeneron Reports Second Quarter 2026 Financial and Operating ResultsRegeneron Pharmaceuticals reported a 17% increase in revenues for the second quarter of 2026.
    globenewswire.com
  9. Investment
    FDA to fast-track Regeneron drug facility in Saratoga CountyRegeneron Pharmaceuticals is building a 1 million-square-foot drug development and manufacturing facility in Saratoga Springs, a project expected to cost $2 billion.
    timesunion.com
  10. In development
    Regeneron and CytomX extend cancer therapy partnership to $4bn deal.
    pharmaceutical-business-review.com

Showing 10 of 26 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Regeneron with the Signal API

One POST /v1/companies/enrich call with regeneron.com returns Regeneron news signals (news), each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"regeneron.com","signal_types":["news"],"limit":20}'

Same industry

News at related companies

Questions about Regeneron news

What is the latest news on Regeneron?
The newest event on this page is dated Sep 24, 2026. globenewswire.com reported: Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026. This page lists 26 dated events for Regeneron, each with a source link.
What is going on with Regeneron?
The 10 latest events on this page cover earnings (1), in development (4), launch (1), integration (1), investment (2) and revenue (1). The newest: Sep 24, 2026: Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026 (globenewswire.com).

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →